Eli Lilly and Company
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 26.8 | – | 47.5 | 27.0 | 33.4 | 30.8 | 25.4 | 29.7 | 34.2 | 31.3 | 21.3 | 19.7 | – | 9.1 | 7.6 | 10.7 | 13.8 | 12.2 | 32.1 | 38.7 | 29.6 | – | 37.0 | 15.1 | 26.1 | 47.2 | 55.7 | 100.5 | 65.9 | 46.8 | |
| 5.8 | 9.9 | 10.8 | 7.4 | 9.4 | 7.4 | 6.2 | 6.0 | 4.5 | 4.2 | 3.6 | 3.1 | 2.2 | 1.8 | 1.7 | 1.9 | 2.5 | 2.5 | 3.9 | 4.7 | 3.8 | 4.5 | 5.6 | 5.6 | 6.6 | 9.3 | 12.2 | 15.4 | 15.5 | 14.8 | |
| 6.7 | 16.9 | 22.5 | 14.7 | 16.9 | 12.0 | 8.3 | 7.8 | 5.7 | 5.7 | 5.2 | 4.3 | 6.5 | 4.1 | 3.1 | 3.4 | 3.8 | 3.2 | 5.0 | 6.4 | 5.8 | 7.7 | 11.0 | 48.3 | 28.6 | 29.3 | 32.6 | 48.9 | 49.2 | 36.4 | |
| 5.9 | 9.6 | 10.6 | 7.0 | 9.3 | 7.5 | 6.5 | 6.2 | 4.6 | 4.5 | 3.6 | 3.2 | 2.4 | 1.9 | 1.7 | 2.0 | 2.6 | 2.5 | 4.1 | 4.9 | 4.1 | 4.8 | 5.8 | 6.2 | 7.1 | 9.8 | 12.7 | 16.1 | 16.2 | 15.3 | |
| 15.9 | 26.1 | 29.7 | 18.4 | 25.2 | 20.6 | 18.8 | 19.3 | 14.8 | 14.9 | 11.6 | 10.3 | 1,133.3 | 6.0 | 4.9 | 6.9 | 8.2 | 7.8 | 17.8 | 22.3 | 17.2 | 23.4 | 22.6 | 20.1 | 19.6 | 34.4 | 41.8 | 64.1 | 47.8 | 35.8 | |
| 26.3 | 38.7 | 45.1 | 35.2 | 33.4 | 30.8 | 73.2 | 39.2 | 63.8 | 100.6 | 19.5 | 14.3 | 6.9 | 11.3 | 6.8 | 8.4 | 13.3 | 12.3 | 26.5 | 69.6 | 21.6 | 25.8 | 47.7 | 36.1 | 36.1 | 48.9 | 75.6 | – | 1,684.6 | 107.6 | |
| 3.8% | 2.6% | 2.2% | 2.8% | 3.0% | 3.2% | 1.4% | 2.6% | 1.6% | 1.0% | 5.1% | 7.0% | 14.4% | 8.9% | 14.7% | 12.0% | 7.5% | 8.1% | 3.8% | 1.4% | 4.6% | 3.9% | 2.1% | 2.8% | 2.8% | 2.0% | 1.3% | -0.6% | 0.1% | 0.9% | |
| Margins | ||||||||||||||||||||||||||||||
| 81.0% | 82.0% | 83.5% | 83.4% | 85.1% | 81.3% | 80.4% | 78.7% | 76.7% | 76.3% | 77.4% | 77.2% | 78.5% | 80.6% | 81.1% | 79.1% | 78.8% | 78.8% | 74.9% | 74.8% | 73.1% | 77.7% | 78.2% | 78.8% | 77.7% | 74.2% | 76.8% | 79.2% | 81.3% | 83.8% | |
| 29.2% | 30.5% | 30.6% | 33.6% | 32.8% | 32.3% | 30.0% | 27.8% | 26.4% | 24.9% | 26.3% | 25.8% | 27.1% | 29.2% | 29.3% | 26.0% | 22.2% | 24.0% | 17.0% | 18.0% | 18.2% | 21.3% | 28.0% | 26.9% | 29.4% | 28.0% | 30.3% | 31.6% | 38.9% | 45.6% | |
| 21.8% | -4.8% | 22.7% | 27.2% | 28.2% | 24.1% | 24.4% | 20.4% | 13.1% | 13.5% | 17.0% | 15.8% | -10.2% | 19.8% | 22.0% | 17.9% | 18.1% | 20.3% | 12.2% | 12.1% | 12.9% | -1.0% | 15.0% | 37.3% | 25.2% | 19.7% | 21.9% | 15.4% | 23.5% | 31.7% | |
| 22.1% | 25.5% | 23.9% | 20.9% | 28.1% | 24.1% | 8.5% | 15.4% | 7.0% | 4.2% | 18.5% | 21.9% | 31.2% | 15.9% | 24.6% | 22.8% | 18.8% | 20.1% | 14.7% | 6.7% | 17.7% | 17.3% | 11.7% | 15.6% | 18.2% | 19.0% | 16.1% | -9.2% | 0.9% | 13.8% | |
| Returns | ||||||||||||||||||||||||||||||
| 25.0% | -8.3% | 47.4% | 54.3% | 50.6% | 39.1% | 32.7% | 26.2% | 16.6% | 18.3% | 24.2% | 21.9% | -30.8% | 45.5% | 40.8% | 32.1% | 27.7% | 26.6% | 15.5% | 16.5% | 19.5% | -1.8% | 29.6% | 319.1% | 109.8% | 62.2% | 58.6% | 48.6% | 74.6% | 77.8% | |
| 10.6% | -3.1% | 16.7% | 21.2% | 20.8% | 16.9% | 14.2% | 11.8% | 7.3% | 8.1% | 12.1% | 11.0% | -7.1% | 15.8% | 16.4% | 12.9% | 11.9% | 13.3% | 6.6% | 6.8% | 7.1% | -0.5% | 7.4% | 21.2% | 13.3% | 11.4% | 12.6% | 8.2% | 13.5% | 18.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| 399 | -1,720 | -1,314 | -3,459 | -1,297 | 716 | 2,958 | 2,128 | 1,147 | 3,492 | 605 | 1,787 | 4,965 | 2,199 | 933 | 1,065 | 1,513 | 1,383 | 4,185 | 4,312 | 5,723 | 7,111 | 5,421 | 12,980 | 12,938 | 13,066 | 14,172 | 22,407 | 30,376 | 35,340 | |
| 0.2 | -0.6 | -0.4 | -0.9 | -0.3 | 0.2 | 0.8 | 0.5 | 0.3 | 0.8 | 0.1 | 0.3 | 114.7 | 0.3 | 0.1 | 0.2 | 0.2 | 0.2 | 0.9 | 1.0 | 1.1 | 1.7 | 1.0 | 1.9 | 1.5 | 1.6 | 1.6 | 2.6 | 2.0 | 1.3 | |
| 42.6% | 36.9% | 35.2% | 39.1% | 41.2% | 43.2% | 43.4% | 45.0% | 43.9% | 43.9% | 50.0% | 50.4% | 23.1% | 34.7% | 40.1% | 40.2% | 42.9% | 50.0% | 42.3% | 41.0% | 36.1% | 25.8% | 24.8% | 6.6% | 12.1% | 18.4% | 21.5% | 16.8% | 18.0% | 23.6% | |
| 0.2 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.3 | 0.4 | 1.6 | 0.7 | 0.6 | 0.5 | 0.4 | 0.3 | 0.5 | 0.5 | 0.7 | 1.2 | 1.2 | 5.9 | 2.9 | 1.9 | 1.5 | 2.3 | 2.4 | 1.6 | |
| Per Share | ||||||||||||||||||||||||||||||
| 1.36 | -0.34 | 1.87 | 2.46 | 2.79 | 2.55 | 2.50 | 2.37 | 1.66 | 1.81 | 2.45 | 2.71 | -1.89 | 3.94 | 4.58 | 3.90 | 3.57 | 4.19 | 2.15 | 2.18 | 2.49 | -0.19 | 3.13 | 8.69 | 6.47 | 5.85 | 6.57 | 5.80 | 11.71 | 22.98 | |
| 6.26 | 7.07 | 8.24 | 9.04 | 9.91 | 10.59 | 10.23 | 11.65 | 12.71 | 13.39 | 14.44 | 17.08 | 18.61 | 19.88 | 20.87 | 21.80 | 19.72 | 20.70 | 17.66 | 18.06 | 19.28 | 18.99 | 20.79 | 23.31 | 25.65 | 29.69 | 30.04 | 37.78 | 49.82 | 72.58 | |
| 5.46 | 4.11 | 3.95 | 4.53 | 5.52 | 6.52 | 7.64 | 9.04 | 10.01 | 9.87 | 10.10 | 12.38 | 6.15 | 8.67 | 11.23 | 12.16 | 12.88 | 15.79 | 13.84 | 13.18 | 12.72 | 11.02 | 10.55 | 2.72 | 5.90 | 9.42 | 11.21 | 11.93 | 15.70 | 29.55 | |
| 1.39 | 1.80 | 1.97 | 1.89 | 2.79 | 2.55 | 0.87 | 1.80 | 0.89 | 0.56 | 2.67 | 3.73 | 5.80 | 3.17 | 5.13 | 4.97 | 3.72 | 4.16 | 2.60 | 1.21 | 3.41 | 3.28 | 2.42 | 3.64 | 4.67 | 5.65 | 4.84 | -3.49 | 0.46 | 9.99 | |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.